4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Acetazolamide-induced weakness in paramyotonia congenita.

      , ,
      Annals of internal medicine

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acetazolamide has been shown to be effective prophylaxis for both hypokalemic and hyperkalemic paralysis. A patient with paramyotonia congenita, a related disorder with myotonia and episodic weakness, was studied during treatment with acetazolamide. Athough the patient's myotonia was virtually abolished, severe quadriparesis was produced during each trial of acetazolamide. This response distinguished this patient's condition from other forms of familial periodic paralysis and suggests that acetazolamide may be deleterious to some patients with periodic paralysis.

          Related collections

          Author and article information

          Journal
          Ann. Intern. Med.
          Annals of internal medicine
          0003-4819
          0003-4819
          Feb 1977
          : 86
          : 2
          Article
          835937
          51775760-d704-4a22-b0b0-49ff27dc44c8
          History

          Comments

          Comment on this article